This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Robin Portman
Chair
Overview
Robin Portman is the Chair of the Board of Directors of 趣赢平台. She has 32 years of leadership experience in business development and management in the health care and government contracting arenas. Portman is the recent Chairman, President, and CEO of Atlas Research LLC, a health services management and technology consulting firm from which she retired in 2021. Prior to Atlas, Portman was with Booz Allen Hamilton for 20+ years and held the title of Executive Vice President and Head of Corporate Growth, and Deputy Chief Administrative Officer. Her career also included the positions of Program Manager at TRW, Scientific and Technical Intelligence Analyst for the U.S. Department of the Navy, and teaching positions at Georgetown University.
Education
- MS, Management Information Systems, University of Maryland
- BA, Education, University of Maryland
-
Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline results and costs of a cluster-randomized trial
American Journal of Ophthalmology
January 2023
L.A. Hark, J.D. Horowitz, P. Gorroochurn, L. Park, Q. Wang, D.F. Diamond, N. Harizman, et al.
DOILink for: Manhattan Vision Screening and Follow-up Study (NYC-SIGHT): Baseline results and costs of a cluster-randomized trial -
Omega-3 fatty acid supplementation and fecundability
Human Reproduction
January 2022
J. Stanhiser, A.M.Z. Jukic, D.R. McConnaughey, A.Z. Steiner
DOILink for: Omega-3 fatty acid supplementation and fecundability -
Use and impact of type 2 diabetes prevention interventions
63,
American Journal of Preventive Medicine
January 2022
Joanne Campione, N.D. Ritchie, H.A. Fishbein, R.E. Mardon, M.C. Johnson, W. Pace, R.J. Birch, et al.
DOILink for: Use and impact of type 2 diabetes prevention interventions